# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-26-021980
Filing Date
2026-05-08
Accepted
2026-05-08 16:15:33
Documents
17
Period of Report
2026-05-08

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | formdef14a.htm iXBRL | DEF 14A | 804716
2 | GRAPHIC | formdef14a_001.jpg | GRAPHIC | 6939
3 | GRAPHIC | proxy_001.jpg | GRAPHIC | 405310
4 | GRAPHIC | proxy_002.jpg | GRAPHIC | 409317
| Complete submission text file | 0001493152-26-021980.txt |  | 3314954

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL SCHEMA FILE | aztr-20251231.xsd | EX-101.SCH | 3419
6 | XBRL DEFINITION FILE | aztr-20251231_def.xml | EX-101.DEF | 3367
7 | XBRL LABEL FILE | aztr-20251231_lab.xml | EX-101.LAB | 53134
8 | XBRL PRESENTATION FILE | aztr-20251231_pre.xml | EX-101.PRE | 41980
20 | EXTRACTED XBRL INSTANCE DOCUMENT | formdef14a_htm.xml | XML | 3588

Mailing Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405
Business Address 21 BUSINESS PARK DRIVE, SUITE 6 BRANFORD CT 06405 (203) 489-0183
Azitra, Inc. (Filer) CIK: 0001701478 (see all company filings)

EIN.: 464478536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41705 | Film No.: 26958554
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)